APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature - Wikidata - awgldk - TriplyDB

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

http://www.wikidata.org/entity/Q37024041

about

Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.Neuropathologic assessment of dementia markers in identical and fraternal twins.The overlap between vascular disease and Alzheimer's disease--lessons from pathology.Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes APOE and cerebral amyloid angiopathy in community-dwelling older persons.Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice The neuropathology and cerebrovascular mechanisms of dementia APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL The role of APOE in cerebrovascular dysfunction APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice.Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA.Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia.Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function.Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals.

P2860

Q27014964-080E94D4-FA57-4E81-A362-55EED84D903F Q33616238-F238D458-924E-435F-A868-AA70321501A0 Q33784747-5DD2F826-B373-4346-94BB-D07468621736 Q34484708-2D12505D-8C1C-403D-9763-F1D818DE2440 Q34842317-79B1AA5F-E9F2-4AE4-9BA6-2C519247F660 Q36037652-995100E1-63D1-427E-95AE-368EEC1FE2B1 Q36173680-C2026A88-3AC8-45CC-8670-A50A4AEA1825 Q36270381-F4D490AA-9E3A-4185-975B-4763B9E2965C Q36393038-959F0745-2B5A-4753-BFAF-DBD67CF060EA Q36593201-25756465-490D-4D35-BFF7-8B9337A1BF58 Q36593238-C8E8F960-0E1B-4E23-AA62-C18A0BD9197F Q36813704-5BE089C0-D9D9-4FCB-A5A7-AD50997845B5 Q37133286-7F287C84-9E21-4C73-9E3B-54AD7700B24E Q37557940-F2BBECC3-E358-4DEE-A3D2-BCDD88DD64E0 Q38292899-26BA2FB2-44C9-43E3-A55A-020798EA64D8 Q38407944-BC06A63B-F2A3-48B5-BEE4-8B6E6EBADD08 Q38684307-0A315D8D-AE4A-4AE5-8920-FB31F16C8A5B Q39155261-05BE3D80-0614-403B-844F-87625B35AA2D Q39873829-5FF2D71B-22F0-464C-93D8-C2ECF16B2736 Q40135861-90FBC52D-9514-4BEC-BF19-633CCB35B08D

P2860

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

http://www.wikidata.org/entity/Q37024041

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

@en

APOE-ε2 and APOE-ε4 correlate ...... ation in cerebral vasculature.

@nl

type

label

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

@en

APOE-ε2 and APOE-ε4 correlate ...... ation in cerebral vasculature.

@nl

prefLabel

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

@en

APOE-ε2 and APOE-ε4 correlate ...... ation in cerebral vasculature.

@nl

P1433

Q37024041-13A99B68-BAA9-46F5-BBB9-AC03CE8A960D

P1476

Q37024041-94F7BDC8-2E79-4484-86D0-FB57F07FF847

P2093

Q37024041-16B9B021-3418-4A62-A2D9-C8A90396593A

Q37024041-5132011A-0C09-4318-A98F-95527D1DD655

Q37024041-5EE42034-EB1F-4DC5-9A89-FB9F0D6291F7

Q37024041-CB4CD26E-2C02-459B-B8EC-D46546750CFC

Q37024041-CFBEFEA6-FD9C-41CE-8DF4-C6CED3F0DA14

Q37024041-E906397C-A48A-4D03-B7F7-5EBC5688A9BE

Q37024041-F96F8A2F-CF73-453C-B30E-9B23D22C4637

P2860

Q37024041-07AEB5D1-4FD1-4155-A1D8-D9C347CA3A46

Q37024041-09598107-BCAE-4BA7-86FA-7CE3C3DEF9D9

Q37024041-1254CF05-73CD-4C05-90E5-734CCE2E6F29

Q37024041-13E10288-BDD5-4184-9159-B869F6AA13F9

Q37024041-1F5B5D69-D34B-4621-8254-F98C28838085

Q37024041-227D55E3-41EC-4F2E-A80B-75269C6D0DC2

Q37024041-27B88467-8DCE-4449-BE79-91D8C0F25CF2

Q37024041-2AE8F807-0033-44BA-80B4-7DE3E6B3FCEE

Q37024041-2FCBD0F7-6A37-412F-B877-C1452D7E3CA5

Q37024041-39E6224E-F00E-42C0-8E09-8704DF032D5C

P304

Q37024041-CF4E885C-7A83-400C-A35F-1B3CE49B84C7

P31

Q37024041-FC60FB43-64AC-4D4D-8A23-1B83B21D8117

P356

Q37024041-2EC4F3BD-00D3-4D8D-AB3B-2DDF54F28E26

P433

Q37024041-FB8B612B-F0E3-4407-A81F-3555D80661DB

P478

Q37024041-BF39F4F1-7CA8-4B0E-ABFC-0F8EE1FC46C0

P577

Q37024041-C591029B-C1CE-4873-BD7A-0099D55FDB1E

P698

Q37024041-D2EB6FAB-5B24-4A49-85CA-E49AFFCE4C10

P932

Q37024041-B82B42F8-8D6C-4196-BF58-43AAA3E219D9

P356

NEN.0B013E31829A25B9

P1433

Journal of Neuropathology & Experimental Neurology

P1476

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature

@en

P2093

David W Fardo

http://www.w3.org/2001/XMLSchema#string

Donna M Wilcock

http://www.w3.org/2001/XMLSchema#string

G William Rebeck

http://www.w3.org/2001/XMLSchema#string

Gregory A Jicha

http://www.w3.org/2001/XMLSchema#string

Nina M Pious

http://www.w3.org/2001/XMLSchema#string

Peter T Nelson

http://www.w3.org/2001/XMLSchema#string

Steven Estus

http://www.w3.org/2001/XMLSchema#string

P2860

The genetics and neuropathology of Alzheimer's disease

Clinical trial methodologies for disease-modifying therapeutic approaches

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.

Cerebral amyloid angiopathy in the elderly

Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Microinfarct pathology, dementia, and cognitive systems.

P304

708-715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/NEN.0B013E31829A25B9

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23771217

http://www.w3.org/2001/XMLSchema#string

P932

3715146

http://www.w3.org/2001/XMLSchema#string